Bristol-Myers Squibb Company v. McNeil-P.P.C., Inc.
United States Court of Appeals for the Second Circuit
973 F.2d 1033 (1992)
- Written by Craig Conway, LLM
Facts
Bristol-Myers Squibb Company (Bristol) (plaintiff) manufactured and distributed Excedrin PM, a product combining an analgesic with a sleep aid, starting in 1968. McNeil-P.P.C., Inc. (McNeil) (defendant), also a pharmaceutical company, manufactured and distributed Tylenol PM, a combination of analgesic and sleep aid, starting in 1991. Neither brand registered the trademark “PM.” Bristol filed suit against McNeil in the United States District Court for the Eastern District of New York, seeking relief under the Lanham Act and moving for a preliminary injunction to prevent McNeil from using the term “PM” in connection with McNeil’s combination analgesic/sleep aid and to prevent the marketing of the product. The district court denied Bristol’s requested injunction, finding that “PM” was a descriptive term that denoted nighttime without secondary meaning. Bristol appealed.
Rule of Law
Issue
Holding and Reasoning (Meskill, J.)
What to do next…
Here's why 832,000 law students have relied on our case briefs:
- Written by law professors and practitioners, not other law students. 46,500 briefs, keyed to 994 casebooks. Top-notch customer support.
- The right amount of information, includes the facts, issues, rule of law, holding and reasoning, and any concurrences and dissents.
- Access in your classes, works on your mobile and tablet. Massive library of related video lessons and high quality multiple-choice questions.
- Easy to use, uniform format for every case brief. Written in plain English, not in legalese. Our briefs summarize and simplify; they don’t just repeat the court’s language.